Summary
The product HGH (10iu/vial), manufactured by ironlion-lab, underwent independent testing to verify its authenticity and potency. The sample, with an unknown batch number, was submitted by ironlion-lab and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of recombinant human growth hormone (rHGH), with a total concentration of 4.12 mg / 12.36 IU per vial. The product’s purity was determined to be 96.992%, with no detectable dimer or related proteins.
The testing process began on 31 July 2024, with the sample received on 12 August 2024, and analysis completed on 14 August 2024. While the results confirm high purity and slightly increased potency, scrutiny of manufacturer-submitted samples remains essential to ensure reliability. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: ironlion-lab
- Product Name: HGH (10iu/vial)
- Active Ingredient: Recombinant Human Growth Hormone (rHGH)
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Viral Powder
Sample Acquisition and Testing
- Task Number: #47032
- Testing Ordered: 31 July 2024
- Sample Received: 12 August 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: ironlion-lab (Manufacturer)
- Analysis Paid For By: ironlion-lab (Manufacturer)
Testing Results
- Amount of rHGH in the Vial: 4.12 mg / 12.36 IU
- Purity: 96.992%
Verification Details
Verification URL: https://janoshik.com/tests/47032_2DRH9Z6MAFJ7
Evaluation of Manufacturer-Submitted Testing
This analysis highlights that HGH (10iu/vial) contains recombinant human growth hormone (rHGH) at a high purity level of 96.992%, with a measured amount of 4.12 mg / 12.36 IU per vial, slightly exceeding the labeled 10 IU specification. The absence of dimer and related proteins suggests minimal degradation and a well-formulated product. However, since the test was submitted and funded by ironlion-lab, careful evaluation is necessary to assess product consistency across different batches. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple samples.
Conclusion
The analysis confirms that HGH (10iu/vial) contains 4.12 mg / 12.36 IU per vial, which slightly exceeds the labeled 10 IU specification. The high purity (96.992%) and absence of dimer and related proteins suggest strong manufacturing quality. However, further independent third-party testing is encouraged to validate consistency across different batches. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding pharmaceutical and peptide products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
